171 related articles for article (PubMed ID: 28915064)
1. The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.
Maselli DJ; Medina JL; Brooks EG; Coalson JJ; Kannan TR; Winter VT; Principe M; Cagle MP; Baseman JB; Dube PH; Peters JI
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):253-260. PubMed ID: 28915064
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice.
Medina JL; Coalson JJ; Brooks EG; Le Saux CJ; Winter VT; Chaparro A; Principe MF; Solis L; Kannan TR; Baseman JB; Dube PH
PLoS One; 2014; 9(7):e102613. PubMed ID: 25058417
[TBL] [Abstract][Full Text] [Related]
3. Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice.
Medina JL; Brooks EG; Chaparro A; Dube PH
PLoS One; 2017; 12(2):e0172447. PubMed ID: 28199385
[TBL] [Abstract][Full Text] [Related]
4. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.
Kannan TR; Musatovova O; Balasubramanian S; Cagle M; Jordan JL; Krunkosky TM; Davis A; Hardy RD; Baseman JB
Mol Microbiol; 2010 Jun; 76(5):1127-41. PubMed ID: 20199607
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.
Hardy RD; Coalson JJ; Peters J; Chaparro A; Techasaensiri C; Cantwell AM; Kannan TR; Baseman JB; Dube PH
PLoS One; 2009 Oct; 4(10):e7562. PubMed ID: 19859545
[TBL] [Abstract][Full Text] [Related]
6.
Ramasamy K; Balasubramanian S; Manickam K; Pandranki L; Taylor AB; Hart PJ; Baseman JB; Kannan TR
mBio; 2018 Jan; 9(1):. PubMed ID: 29362229
[No Abstract] [Full Text] [Related]
7. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.
Kannan TR; Coalson JJ; Cagle M; Musatovova O; Hardy RD; Baseman JB
J Infect Dis; 2011 Nov; 204(10):1596-604. PubMed ID: 21957154
[TBL] [Abstract][Full Text] [Related]
8. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.
Techasaensiri C; Tagliabue C; Cagle M; Iranpour P; Katz K; Kannan TR; Coalson JJ; Baseman JB; Hardy RD
Am J Respir Crit Care Med; 2010 Sep; 182(6):797-804. PubMed ID: 20508214
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma pneumoniae in children with acute and refractory asthma.
Wood PR; Hill VL; Burks ML; Peters JI; Singh H; Kannan TR; Vale S; Cagle MP; Principe MF; Baseman JB; Brooks EG
Ann Allergy Asthma Immunol; 2013 May; 110(5):328-334.e1. PubMed ID: 23622002
[TBL] [Abstract][Full Text] [Related]
10. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.
Medina JL; Coalson JJ; Brooks EG; Winter VT; Chaparro A; Principe MF; Kannan TR; Baseman JB; Dube PH
Am J Respir Cell Mol Biol; 2012 Jun; 46(6):815-22. PubMed ID: 22281984
[TBL] [Abstract][Full Text] [Related]
11. ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.
Bose S; Segovia JA; Somarajan SR; Chang TH; Kannan TR; Baseman JB
mBio; 2014 Dec; 5(6):. PubMed ID: 25538194
[TBL] [Abstract][Full Text] [Related]
12. Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.
Balasubramanian S; Pandranki L; Maupin S; Ramasamy K; Taylor AB; Hart PJ; Baseman JB; Kannan TR
Cell Microbiol; 2019 Aug; 21(8):e13032. PubMed ID: 30977272
[TBL] [Abstract][Full Text] [Related]
13. Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.
Somarajan SR; Al-Asadi F; Ramasamy K; Pandranki L; Baseman JB; Kannan TR
mBio; 2014 Aug; 5(4):. PubMed ID: 25139904
[TBL] [Abstract][Full Text] [Related]
14. Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.
Peters J; Singh H; Brooks EG; Diaz J; Kannan TR; Coalson JJ; Baseman JG; Cagle M; Baseman JB
Chest; 2011 Aug; 140(2):401-407. PubMed ID: 21622549
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.
Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
Microbiol Spectr; 2021 Dec; 9(3):e0158821. PubMed ID: 34937175
[TBL] [Abstract][Full Text] [Related]
16. Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice.
Yoshikawa E; Tamiya S; Inoue Y; Suzuki K; Yoshioka Y
Biochem Biophys Res Commun; 2022 Feb; 594():81-87. PubMed ID: 35078111
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections.
Xue G; Zhao H; Yan C; Li S; Cui J; Feng Y; Xie X; Yuan J
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1705-1711. PubMed ID: 33733396
[TBL] [Abstract][Full Text] [Related]
18. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Mycoplasma pneumoniae: An update.
Chaudhry R; Ghosh A; Chandolia A
Indian J Med Microbiol; 2016; 34(1):7-16. PubMed ID: 26776112
[TBL] [Abstract][Full Text] [Related]
20. High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.
Li G; Fan L; Wang Y; Huang L; Wang M; Zhu C; Hao C; Ji W; Liang H; Yan Y; Chen Z
Mol Med; 2019 Aug; 25(1):38. PubMed ID: 31399022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
